BXP
23
6
INTU
39
4
HAS
72
-2
GOOGL
42
-3
PNW
60
-2
BIIB
63
10
CMI
71
9
GLW
94
6
HSIC
62
6
AAL
26
8
OKE
48
3
ITW
74
3
AN
50
10
KMI
85
2
HPE
71
7
WEC
45
2
NWSA
33
-4
HOG
49
4
OI
75
2
XRX
32
8
BXP
23
6
INTU
39
4
HAS
72
-2
GOOGL
42
-3
PNW
60
-2
BIIB
63
10
CMI
71
9
GLW
94
6
HSIC
62
6
AAL
26
8
OKE
48
3
ITW
74
3
AN
50
10
KMI
85
2
HPE
71
7
WEC
45
2
NWSA
33
-4
HOG
49
4
OI
75
2
XRX
32
8
Financhill
Back

Cardiac Biotech Solutions, Inc. 10K Form

Buy
69

CBSC
Cardiac Biotech Solutions, Inc.

Last Price:
$0.05
Seasonality Move:
25.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CBSC News And Ratings

See the #1 stock for the next 7 days that we like better than CBSC

CBSC Financial Statistics

Sales & Book Value

Annual Sales: $41.4K
Cash Flow: $-181.5K
Price / Cash Flow: 0
Annual Sales: $-0.01
Price / Book: 0

Profitability

EPS (TTM): -0.00730
Net Income (TTM): $-1.4M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: -543.36%

Cardiac Biotech Solutions, Inc. Earnings Forecast

Key Cardiac Biotech Solutions, Inc. Financial Ratios

  • The Gross Profit Margin over the past 10 years for CBSC is 0.00%.
  • The Selling, General & Administrative Expenses for CBSC have been equal to 2,888.89% of Gross Profit Margin.
  • The Research & Development expenses have been 418.36% of Revenue.
  • The Net Earning history of CBSC is -4,059.66% of Total Revenues.
  • Per Share Earnings over the last 10 years have been positive in 5 years.

Cardiac Biotech Solutions, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CBSC
Website: cbscientificinc.com

Debt

Debt-to-Equity Ratio: -0.12
Current Ratio: 0.15
Quick Ratio: 0.12

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CBSC Technical Analysis vs Fundamental Analysis

Buy
69
Cardiac Biotech Solutions, Inc. (CBSC) is a Buy

Is Cardiac Biotech Solutions, Inc. a Buy or a Sell?